ArticleTherapeutic advances in medical oncology2020

Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Zhibo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.